(Q81517505)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968996%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968996%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968996%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Tiaynu Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968996%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Mark K Buyyounouski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968996%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Eric Ross

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968996%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Robert G Uzzo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968996%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Alan Pollack

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968996%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Eric M Horwitz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968996%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968996%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968996%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968996%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968996%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

55-60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968996%20AND%20SRC:MED&resulttype=core&format=json

Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. American Society of Therapeutic Radiology and Oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

PSA failure and the risk of death in prostate cancer patients treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

Both pretreatment prostate-specific antigen level and posttreatment biochemical failure are independent predictors of overall survival after radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

Patterns and fate of PSA bouncing following 3D-CRT

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

An ICRU 50 radiotherapy treatment chart.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

Definitions of biochemical failure in prostate cancer following radiation therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

The 100-day PSA: usefulness as surrogate end point for biochemical disease-free survival after definitive radiotherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

What dose of external-beam radiation is high enough for prostate cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

Practical application of biochemical failure definitions: what to do and when to do it

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23139

7 January 2021

Identifiers

DOI

10.1002/CNCR.23139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968996%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference